BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32579274)

  • 1. Focused cardiac ultrasound and point-of-care NT-proBNP assay in the emergency room for differentiation of cardiac and noncardiac causes of respiratory distress in cats.
    Janson CO; Hezzell MJ; Oyama MA; Harries B; Drobatz KJ; Reineke EL
    J Vet Emerg Crit Care (San Antonio); 2020 Jul; 30(4):376-383. PubMed ID: 32579274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of focused cardiac ultrasound in the emergency room for differentiation of respiratory and cardiac causes of respiratory distress in dogs.
    Hezzell MJ; Ostroski C; Oyama MA; Harries B; Drobatz KJ; Reineke EL
    J Vet Emerg Crit Care (San Antonio); 2020 Mar; 30(2):159-164. PubMed ID: 32067327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of blood cardiac troponin I concentrations obtained with a cage-side analyzer to differentiate cats with cardiac and noncardiac causes of dyspnea.
    Wells SM; Shofer FS; Walters PC; Stamoulis ME; Cole SG; Sleeper MM
    J Am Vet Med Assoc; 2014 Feb; 244(4):425-30. PubMed ID: 24479456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of point-of-care thoracic ultrasound and NT-proBNP for the diagnosis of congestive heart failure in cats with respiratory distress.
    Ward JL; Lisciandro GR; Ware WA; Viall AK; Aona BD; Kurtz KA; Reina-Doreste Y; DeFrancesco TC
    J Vet Intern Med; 2018 Sep; 32(5):1530-1540. PubMed ID: 30216579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements.
    Hezzell MJ; Rush JE; Humm K; Rozanski EA; Sargent J; Connolly DJ; Boswood A; Oyama MA
    J Vet Intern Med; 2016; 30(2):536-42. PubMed ID: 26813037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation.
    Machen MC; Oyama MA; Gordon SG; Rush JE; Achen SE; Stepien RL; Fox PR; Saunders AB; Cunningham SM; Lee PM; Kellihan HB
    J Vet Cardiol; 2014 Dec; 16(4):245-55. PubMed ID: 25456274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the vertebral heart scale for differentiation of cardiac and noncardiac causes of respiratory distress in cats: 67 cases (2002-2003).
    Sleeper MM; Roland R; Drobatz KJ
    J Am Vet Med Assoc; 2013 Feb; 242(3):366-71. PubMed ID: 23327180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing cardiac and noncardiac dyspnea in 48 dogs using plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I.
    Prosek R; Sisson DD; Oyama MA; Solter PF
    J Vet Intern Med; 2007; 21(2):238-42. PubMed ID: 17427383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
    Fox PR; Oyama MA; Hezzell MJ; Rush JE; Nguyenba TP; DeFrancesco TC; Lehmkuhl LB; Kellihan HB; Bulmer B; Gordon SG; Cunningham SM; MacGregor J; Stepien RL; Lefbom B; Adin D; Lamb K
    J Vet Intern Med; 2015 Jan; 29(1):171-9. PubMed ID: 25308881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of an N-Terminal Prohormone of Brain Natriuretic Peptide Point-of-Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease.
    Harris AN; Beatty SS; Estrada AH; Winter B; Bohannon M; Sosa I; Hanscom J; Mainville CA; Gallagher AE
    J Vet Intern Med; 2017 Jul; 31(4):994-999. PubMed ID: 28617995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats.
    Loughran KA; Rush JE; Rozanski EA; Oyama MA; Larouche-Lebel É; Kraus MS
    J Vet Intern Med; 2019 Sep; 33(5):1892-1901. PubMed ID: 31317580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of NT-pro-BNP assay on accuracy and confidence of general practitioners in diagnosing heart failure or respiratory disease in cats with respiratory signs.
    Singletary GE; Rush JE; Fox PR; Stepien RL; Oyama MA
    J Vet Intern Med; 2012; 26(3):542-6. PubMed ID: 22458368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats.
    Hassdenteufel E; Henrich E; Hildebrandt N; Stosic A; Schneider M
    J Vet Emerg Crit Care (San Antonio); 2013; 23(4):416-22. PubMed ID: 23859335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice.
    Lu TL; Côté E; Kuo YW; Wu HH; Wang WY; Hung YW
    J Vet Intern Med; 2021 Jul; 35(4):1663-1672. PubMed ID: 33993546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR; Rush JE; Reynolds CA; Defrancesco TC; Keene BW; Atkins CE; Gordon SG; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Macdonald KA; Lehmkuhl LB; Nguyenba TP; Sydney Moise N; Lefbom BK; Hogan DF; Oyama MA
    J Vet Intern Med; 2011; 25(5):1010-6. PubMed ID: 21985136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea.
    Sanz MP; Borque L; Rus A; Vicente B; Ramírez Y; Lasa L
    J Clin Lab Anal; 2006; 20(6):227-32. PubMed ID: 17115420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 1--Cardiac diseases and pulmonary hypertension.
    Smith KF; Quinn RL; Rahilly LJ
    J Vet Emerg Crit Care (San Antonio); 2015; 25(3):311-29. PubMed ID: 26040814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.
    Wurtinger G; Henrich E; Hildebrandt N; Wiedemann N; Schneider M; Hassdenteufel E
    BMC Vet Res; 2017 Dec; 13(1):394. PubMed ID: 29262821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of plasma cardiac troponin I concentration as a means to differentiate cardiac and noncardiac causes of dyspnea in cats.
    Herndon WE; Rishniw M; Schrope D; Sammarco CD; Boddy KN; Sleeper MM
    J Am Vet Med Assoc; 2008 Oct; 233(8):1261-4. PubMed ID: 18922052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.